And what no one has mentioned is that biotec stocks are down 1/2%
Dont know about you but the US markets just dont have the right 'feel'' ATM,especially in this sector.
Caution and hesitation is in the air. IMO
Printable View
And what no one has mentioned is that biotec stocks are down 1/2%
Dont know about you but the US markets just dont have the right 'feel'' ATM,especially in this sector.
Caution and hesitation is in the air. IMO
I dont think that if the US market was open today that PEB would collapse to under $1--my guess its it will be a bit of a ''nowhere'' day maybe losing a few cents.
The $1 is a pretty strong resistance that I think would take more negativity than this to crack.
The US market in general was kind of in a tug of war last night-for the most part neither here nor there.
If the bears win tonight,then you could possibly see the $1 broken--but maybe the bulls will win:)
Its all because of the Russian troops doing a bit of marching practice if you look a bit deeper otherwise the US markets would be higher but like Mac says in reference to PEB its really of interest only to the Lab rats with poor longterm vision otherwise it business as usual for us normal rats:cool:
Lol. I suppose we could say nasdaq is down until it exceeds it highest level. Thanks for all the info but for a simple soul closing price at 1600 will do as a daily benchmark for me. Up 21 I see.
Damn- its after hours now
PEB will probably announce the arrival of tens of thousands of emails requesting sales data
Cheers
I think its more centered on corporate earnings results...Russian troops dont help though--probably makes a bigger difference in Europe
Might be a ''labrat'' day coming up:)
If only we all had that long term vision-It would have been handy a year ago in one way--and a few months ago in another.
I received this from email from David Darling this morning:
Nothing yet from ODT
Dear Mike,
Thank you for your email. That is not a statement made by Chris Swann. We do not give out projections on sales at this stage of our business as you can appreciate there are virtually no comparables in the market and it is very difficult to predict the adoption curve for our product. We do have a number of analysts preparing to do research on the market prospects for this product and for our business. These will come out over the course of the year.
I hope that this helps you.
Regards Dave
I'll go for several tens of thousands anyway.....
Hopefully the share price will now return to the level prior to the statement being issued, now we have that out of the way. Doubt it somehow.